NASDAQ:ARWR
Arrowhead Pharmaceuticals, Inc.
- Stock
Share Trends
Recent Transactions
| Reporter | Filed at | Change (shares) |
|---|---|---|
Hamilton James C Chief Discovery/Trans Medicine Common Stock | 2024-04-03 | -6K −2.85% |
Myszkowski Kenneth Allen Chief Financial Officer Common Stock | 2024-03-08 | -40K −9.08% |
Anzalone Christopher Richard Chief Executive Officer Common Stock | 2024-02-02 | 0 0% |
Oliver Tracie Chief Commercial Officer Common Stock | 2024-01-08 | 74.93K 121.68% |
Myszkowski Kenneth Allen Chief Financial Officer Common Stock | 2024-01-08 | 58.90K 15.43% |
Largest Transactions
| Reporter | Filed at | Change (shares) |
|---|---|---|
Anzalone Christopher Richard Chief Executive Officer Common Stock | 2022-01-04 | 800K 24.65% |
Anzalone Christopher Richard Chief Executive Officer Common Stock | 2019-01-03 | 600K 38.90% |
Anzalone Christopher Richard Chief Executive Officer Common Stock | 2022-12-20 | 252.40K 7.28% |
Given Bruce D Chief Operating Officer Common Stock | 2019-01-03 | 190K 20.92% |
Perry Michael S Director Common Stock | 2019-09-11 | -185K −83.71% |
Transaction Log
| Filing Date | Transaction Date | Reporter | Title | Post Shares | Quantity | T | Stock Class | USD |
|---|---|---|---|---|---|---|---|---|
2024-04-03 | 2024-04-01 | Hamilton James C | Chief Discovery/Trans Medicine | 204.85K | 6K | S | Common Stock | -168.18K |
2024-03-08 | 2024-03-06 | Myszkowski Kenneth Allen | Chief Financial Officer | 400.60K | 40K | S | Common Stock | -1.41M |
2024-02-02 | 2024-01-31 | Anzalone Christopher Richard | Chief Executive Officer | 3.72M | 19.73K | S | Common Stock | -645.37K |
2024-02-02 | 2024-01-31 | Anzalone Christopher Richard | Chief Executive Officer | 3.73M | 37.77K | S | Common Stock | -1.21M |
2024-02-02 | 2024-01-31 | Anzalone Christopher Richard | Chief Executive Officer | 3.77M | 57.50K | M | Common Stock | 836.04K |
2024-01-08 | 2024-01-05 | Myszkowski Kenneth Allen | Chief Financial Officer | 440.60K | 8.90K | S | Common Stock | -317.43K |
2024-01-08 | 2024-01-04 | Oliver Tracie | Chief Commercial Officer | 136.57K | 75K | A | Common Stock | 0 |
2024-01-08 | 2024-01-05 | San Martin Javier | Chief Medical Officer | 202.90K | 3.10K | S | Common Stock | -108.59K |
2024-01-08 | 2024-01-05 | San Martin Javier | Chief Medical Officer | 206K | 800 | S | Common Stock | -27.29K |
2024-01-08 | 2024-01-05 | San Martin Javier | Chief Medical Officer | 198.50K | 4.40K | S | Common Stock | -156.92K |
2024-01-08 | 2024-01-04 | San Martin Javier | Chief Medical Officer | 206.80K | 75K | A | Common Stock | 0 |
2024-01-08 | 2024-01-05 | Myszkowski Kenneth Allen | Chief Financial Officer | 449.50K | 5.80K | S | Common Stock | -202.83K |
2024-01-08 | 2024-01-05 | Oliver Tracie | Chief Commercial Officer | 136.50K | 74 | S | Common Stock | -2.51K |
2024-01-08 | 2024-01-04 | Myszkowski Kenneth Allen | Chief Financial Officer | 456.70K | 75K | A | Common Stock | 0 |
2024-01-08 | 2024-01-05 | Myszkowski Kenneth Allen | Chief Financial Officer | 455.30K | 1.40K | S | Common Stock | -47.66K |
2024-01-05 | 2024-01-05 | O'Brien Patrick | COO and General Counsel | 477.13K | 8.20K | S | Common Stock | -286.92K |
2024-01-05 | 2024-01-03 | Hamilton James C | Director | 175.93K | 500 | S | Common Stock | -16.65K |
2024-01-05 | 2024-01-03 | O'Brien Patrick | COO and General Counsel | 405.93K | 2.80K | S | Common Stock | -91.06K |
2024-01-05 | 2024-01-03 | O'Brien Patrick | COO and General Counsel | 405.53K | 400 | S | Common Stock | -13.36K |
2024-01-05 | 2024-01-03 | Hamilton James C | Director | 176.43K | 2.30K | S | Common Stock | -74.80K |
2024-01-05 | 2024-01-03 | Hamilton James C | Director | 178.73K | 3.50K | S | Common Stock | -111.33K |
2024-01-05 | 2024-01-05 | Hamilton James C | Director | 241.13K | 8K | S | Common Stock | -279.52K |
2024-01-05 | 2024-01-04 | Hamilton James C | Director | 250.93K | 75K | A | Common Stock | 0 |
2024-01-05 | 2024-01-05 | Hamilton James C | Director | 249.13K | 1.80K | S | Common Stock | -61.20K |
2024-01-05 | 2024-01-05 | Hamilton James C | Director | 228.79K | 12.34K | S | Common Stock | -440.03K |
2024-01-05 | 2024-01-04 | O'Brien Patrick | COO and General Counsel | 487.23K | 85K | A | Common Stock | 0 |
2024-01-05 | 2024-01-03 | O'Brien Patrick | COO and General Counsel | 408.73K | 3.85K | S | Common Stock | -122.51K |
2024-01-05 | 2024-01-05 | Hamilton James C | Director | 218.79K | 10K | S | Common Stock | -350K |
2024-01-05 | 2024-01-03 | O'Brien Patrick | COO and General Counsel | 403.83K | 1.70K | S | Common Stock | -55.51K |
2024-01-05 | 2024-01-05 | O'Brien Patrick | COO and General Counsel | 485.33K | 1.90K | S | Common Stock | -64.58K |
2024-01-05 | 2024-01-04 | O'Brien Patrick | COO and General Counsel | 402.23K | 1.60K | S | Common Stock | -52.21K |
2024-01-05 | 2024-01-05 | O'Brien Patrick | COO and General Counsel | 464.38K | 12.74K | S | Common Stock | -454.22K |
2024-01-04 | 2024-01-02 | Anzalone Christopher Richard | Chief Executive Officer | 3.72M | 4.63K | S | Common Stock | -142.45K |
2024-01-04 | 2024-01-02 | Anzalone Christopher Richard | Chief Executive Officer | 3.72M | 5.32K | S | Common Stock | -166.19K |
2023-12-22 | 2023-12-20 | Anzalone Christopher Richard | Chief Executive Officer | 3.73M | 12K | S | Common Stock | -342.48K |
2023-12-19 | 2023-12-15 | Given Douglas B | Director | 132.62K | 14.99K | A | Common Stock | 380.82K |
2023-12-19 | 2023-12-15 | Ferrari Mauro | Director | 65.83K | 14.99K | A | Common Stock | 380.82K |
2023-12-19 | 2023-12-15 | Waddill William D. | Director | 51.80K | 14.99K | A | Common Stock | 380.82K |
2023-12-19 | 2023-12-15 | Vakiener Victoria | Director | 36.72K | 14.99K | A | Common Stock | 380.82K |
2023-12-19 | 2023-12-15 | Perry Michael S | Director | 114.75K | 14.99K | A | Common Stock | 380.82K |
2023-12-19 | 2023-12-15 | Olukotun Adeoye Y | Director | 22.85K | 14.99K | A | Common Stock | 380.82K |
2023-10-27 | 2023-10-25 | Anzalone Christopher Richard | Chief Executive Officer | 3.74M | 24.34K | S | Common Stock | -589.22K |
2023-10-02 | 2023-09-28 | Vakiener Victoria | Director | 21.73K | 1.55K | S | Common Stock | -40.81K |
2023-09-20 | 2023-09-18 | Anzalone Christopher Richard | Chief Executive Officer | 3.79M | 31.52K | S | Common Stock | -882.64K |
2023-09-20 | 2023-09-18 | Anzalone Christopher Richard | Chief Executive Officer | 3.82M | 57.76K | M | Common Stock | 274.34K |
2023-09-20 | 2023-09-18 | Anzalone Christopher Richard | Chief Executive Officer | 3.76M | 26.23K | S | Common Stock | -741.58K |
2023-06-29 | 2023-06-27 | Myszkowski Kenneth Allen | Chief Financial Officer | 381.70K | 15K | S | Common Stock | -543K |
2023-05-08 | 2023-05-05 | Given Douglas B | Director | 117.64K | 6.50K | S | Common Stock | -265.85K |
2023-01-11 | 2023-01-10 | Olukotun Adeoye Y | Director | 19.22K | 7.87K | A | Common Stock | 0 |
2023-01-11 | 2023-01-10 | Given Douglas B | Director | 124.14K | 7.87K | A | Common Stock | 0 |
2023-01-11 | 2023-01-10 | De Backer Marianne | Director | 31.27K | 7.87K | A | Common Stock | 0 |
2023-01-11 | 2023-01-10 | Waddill William D. | Director | 36.82K | 7.87K | A | Common Stock | 0 |
2023-01-11 | 2023-01-10 | Perry Michael S | Director | 99.77K | 7.87K | A | Common Stock | 0 |
2023-01-11 | 2023-01-09 | Waddill William D. | Director | 28.95K | 3.20K | S | Common Stock | -96K |
2023-01-11 | 2023-01-10 | Vakiener Victoria | Director | 15.42K | 1.76K | D | Common Stock | 0 |
2023-01-11 | 2023-01-10 | Vakiener Victoria | Director | 23.28K | 7.87K | A | Common Stock | 0 |
2023-01-06 | 2023-01-05 | Hamilton James C | Director | 198.06K | 7.23K | S | Common Stock | -270.40K |
2023-01-06 | 2023-01-05 | O'Brien Patrick | COO and General Counsel | 413.38K | 7.50K | S | Common Stock | -280.43K |
2023-01-06 | 2023-01-05 | Hamilton James C | Director | 191.48K | 6.57K | S | Common Stock | -245.83K |
2023-01-06 | 2023-01-05 | O'Brien Patrick | COO and General Counsel | 420.88K | 7.50K | S | Common Stock | -280.43K |
2023-01-05 | 2023-01-03 | O'Brien Patrick | COO and General Counsel | 369.23K | 2.89K | S | Common Stock | -108.76K |
2023-01-05 | 2023-01-03 | O'Brien Patrick | COO and General Counsel | 363.94K | 5.29K | S | Common Stock | -203.93K |
2023-01-05 | 2023-01-03 | Hamilton James C | Director | 154.43K | 1.19K | S | Common Stock | -44.73K |
2023-01-05 | 2023-01-04 | San Martin Javier | Chief Medical Officer | 151.50K | 60K | A | Common Stock | 0 |
2023-01-05 | 2023-01-03 | O'Brien Patrick | COO and General Counsel | 363.64K | 300 | S | Common Stock | -11.87K |
2023-01-05 | 2023-01-03 | Hamilton James C | Director | 151.59K | 2.84K | S | Common Stock | -109.31K |
2023-01-05 | 2023-01-04 | Myszkowski Kenneth Allen | Chief Financial Officer | 396.70K | 60K | A | Common Stock | 0 |
2023-01-05 | 2023-01-03 | O'Brien Patrick | COO and General Counsel | 372.13K | 70 | S | Common Stock | -2.86K |
2023-01-05 | 2023-01-03 | Hamilton James C | Director | 145.29K | 247 | S | Common Stock | -10.01K |
2023-01-05 | 2023-01-04 | Hamilton James C | Director | 205.29K | 60K | A | Common Stock | 0 |
2023-01-05 | 2023-01-04 | Oliver Tracie | Chief Commercial Officer | 70.50K | 500 | A | Common Stock | 0 |
2023-01-05 | 2023-01-03 | O'Brien Patrick | COO and General Counsel | 363.38K | 270 | S | Common Stock | -10.94K |
2023-01-05 | 2023-01-03 | O'Brien Patrick | COO and General Counsel | 372.19K | 500 | S | Common Stock | -19.87K |
2023-01-05 | 2023-01-03 | O'Brien Patrick | COO and General Counsel | 372.69K | 5.53K | S | Common Stock | -213.01K |
2023-01-05 | 2023-01-03 | Hamilton James C | Director | 145.53K | 300 | S | Common Stock | -11.87K |
2023-01-05 | 2023-01-04 | O'Brien Patrick | COO and General Counsel | 428.38K | 65K | A | Common Stock | 0 |
2023-01-05 | 2023-01-03 | Hamilton James C | Director | 149.52K | 1.64K | S | Common Stock | -61.56K |
2023-01-05 | 2023-01-03 | Hamilton James C | Director | 151.16K | 136 | S | Common Stock | -5.51K |
2023-01-05 | 2023-01-03 | O'Brien Patrick | COO and General Counsel | 378.22K | 2.65K | S | Common Stock | -99.57K |
2023-01-05 | 2023-01-03 | Hamilton James C | Director | 151.29K | 300 | S | Common Stock | -11.92K |
2023-01-05 | 2023-01-03 | Hamilton James C | Director | 145.83K | 3.68K | S | Common Stock | -141.83K |
2022-12-30 | 2022-12-29 | Myszkowski Kenneth Allen | Chief Financial Officer | 336.70K | 30.63K | S | Common Stock | -1.23M |
2022-12-22 | 2022-12-21 | O'Brien Patrick | General Counsel | 380.88K | 32K | M | Common Stock | 196.80K |
2022-12-20 | 2022-12-16 | Anzalone Christopher Richard | Chief Executive Officer | 3.49M | 18.38K | A | Common Stock | 0 |
2022-12-20 | 2022-12-20 | Anzalone Christopher Richard | Chief Executive Officer | 3.72M | 234.03K | A | Common Stock | 0 |
2022-09-29 | 2022-09-27 | Anzalone Christopher Richard | Chief Executive Officer | 3.47M | 39.08K | M | Common Stock | -1.20M |
2022-09-29 | 2022-09-27 | Anzalone Christopher Richard | Chief Executive Officer | 3.47M | 1.54K | M | Common Stock | -48.13K |
2022-07-11 | 2022-07-07 | Anzalone Christopher Richard | Chief Executive Officer | 4.06M | 2.50K | M | Common Stock | 36.36K |
2022-02-14 | 2022-02-11 | Anzalone Christopher Richard | Chief Executive Officer | 4.06M | 61.48K | S | Common Stock | -3.13M |
2022-02-14 | 2022-02-11 | Anzalone Christopher Richard | Chief Executive Officer | 4.06M | 1.90K | S | Common Stock | -95.97K |
2022-02-14 | 2022-02-11 | Anzalone Christopher Richard | Chief Executive Officer | 4.12M | 42.15K | S | Common Stock | -2.20M |
2022-02-14 | 2022-02-11 | Anzalone Christopher Richard | Chief Executive Officer | 4.20M | 146.39K | M | Common Stock | 759.75K |
2022-02-14 | 2022-02-11 | Anzalone Christopher Richard | Chief Executive Officer | 4.16M | 40.85K | S | Common Stock | -2.17M |
2022-01-07 | 2022-01-07 | Olukotun Adeoye Y | Director | 11.35K | 6.40K | A | Common Stock | 0 |
2022-01-07 | 2022-01-05 | O'Brien Patrick | General Counsel | 353.59K | 5K | S | Common Stock | -312.45K |
2022-01-07 | 2022-01-05 | O'Brien Patrick | General Counsel | 358.59K | 10.35K | S | Common Stock | -640.46K |
2022-01-07 | 2022-01-07 | Given Douglas B | Director | 116.27K | 6.40K | A | Common Stock | 0 |
2022-01-07 | 2022-01-07 | De Backer Marianne | Director | 23.40K | 6.40K | A | Common Stock | 0 |
2022-01-07 | 2022-01-07 | Waddill William D. | Director | 32.15K | 6.40K | A | Common Stock | 0 |
2022-01-07 | 2022-01-05 | O'Brien Patrick | General Counsel | 348.88K | 316 | S | Common Stock | -20.33K |